The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple negative breast cancer
Human Pathology Oct 12, 2017
Wang K, et al. - This research explored the role of the CD4/CD8 ratio of tumor-infiltrating lymphocytes (TILs) at the tumor-host interface in triple negative breast cancer (TNBC). Both the tumor size and nodal status displayed a prominent correlation with survival outcomes. The data yielded additional support for the contention that TILs, as a marker of regional immune escape, exhibited prognostic significance in TNBC progression and that the CD4/CD8 ratio of TILs at the tumor-host interface plays a distinctive role, thus appearing to be of clinical relevance.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries